Pancreatic Cancer Research

ResearcherIuliu Hațieganu University of Medicine and PharmacyActive in the last 2 years

Andrada Seicean

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5809-1334; OpenAlex author ID A5079356189, A5081133695. Sources: OpenAlex.

Their work

Papers
18 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
40
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 18

  1. Discovery of a Secretory Granule Lumen-Enriched Serum Protein Signature in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/medicina62030605↗
  2. Neoadjuvant Treatment Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma-A Systematic Review and Meta-Analysis of Randomized Controlled Tri… Co-author DOI 10.3390/medicina62061049↗
  3. Proteomic Profiling of EUS-FNA Samples Differentiates Pancreatic Adenocarcinoma from Mass-Forming Chronic Pancreatitis. Co-author DOI 10.3390/biomedicines13092199↗
  4. The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study. Co-author DOI 10.1186/s12957-022-02606-1↗
  5. Leptin involvement in the survival of pancreatic adenocarcinoma patients with obesity and diabetes. Last author DOI 10.26355/eurrev_202202_28127↗
  6. Serum JAK/STAT profile is related to the IL expression but not with the outcome in pancreatic adenocarcinoma patients. Co-author DOI 10.14715/cmb/2021.67.3.14↗
  7. Synchronous Pancreatic Tumours: Intraductal Papillary Mucinous Neoplasm with Pancreatic Ductal Adenocarcinoma and Neuroendocrine Tumour: A Case Presentation an… Co-author DOI 10.21614/chirurgia.116.ec.2425↗
  8. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival. Last author DOI 10.15403/jgld-2529↗
  9. Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic canc… Co-author DOI 10.4103/eus.eus_16_19↗
  10. Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma. Last author DOI 10.4251/wjgo.v11.i12.1126↗
  11. IL-6 roles - Molecular pathway and clinical implication in pancreatic cancer - A systemic review. First author DOI 10.1016/j.imlet.2016.11.010↗
  12. Role of computer tomography and endoscopic ultrasonography in assessing portal and superior mesenteric vessels invasion in cephalo-pancreatic adenocarcinoma. First author PMID 29051395↗
  13. Performance of the Standard 22G Needle for Endoscopic Ultrasound-guided Tissue Core Biopsy in Pancreatic Cancer. Co-author DOI 10.15403/jgld.2014.1121.252.ugg↗
  14. New targeted therapies in pancreatic cancer. Co-author DOI 10.3748/wjg.v21.i20.6127↗
  15. Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. First author DOI 10.1002/pmic.201300402↗
  16. Celiac plexus neurolysis in pancreatic cancer: the endoscopic ultrasound approach. Co-author DOI 10.3748/wjg.v20.i1.110↗
  17. Pain palliation by endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. Co-author PMID 23539392↗
  18. Molecular angiogenesis profile as a tool to discriminate chronic pancreatitis (CP) from pancreatic cancer (PC). Co-author DOI 10.1097/mpa.0b013e318205e347↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nadim Al Hajjar · 5 shared papers, 2017–2026 · strength 0.97
  2. Cristina Adela Iuga · 5 shared papers, 2014–2026 · strength 0.89
  3. Radu Seicean · 6 shared papers, 2013–2022 · strength 0.65
  4. Livia Petrusel · 4 shared papers, 2019–2022 · strength 0.55
  5. Emil Ioan Moiș · 2 shared papers, 2026 · strength 0.52
  6. Diana Schlanger · 2 shared papers, 2021–2022 · strength 0.37
  7. Maria Ilies · 2 shared papers, 2021–2022 · strength 0.31
  8. Casandra Teodorescu · 1 shared paper, 2025 · strength 0.28
  9. Radu Vidra · 1 shared paper, 2026 · strength 0.27
  10. Traian Adrian Duse · 1 shared paper, 2026 · strength 0.27
  11. Septimiu Alex Moldovan · 1 shared paper, 2026 · strength 0.25
  12. T Man · 1 shared paper, 2022 · strength 0.16
  13. Cornel Iancu · 2 shared papers, 2014–2017 · strength 0.12
  14. Claudia Cristina Burz · 2 shared papers, 2011–2017 · strength 0.12
  15. Vlad-Vasile Pop · 1 shared paper, 2017 · strength 0.09
  16. Raluca Bodea · 1 shared paper, 2017 · strength 0.07
  17. Constantin Iordache · 1 shared paper, 2017 · strength 0.07
  18. JulioIglesias Garcia · 1 shared paper, 2019 · strength 0.07
  19. Michael Hocke · 1 shared paper, 2019 · strength 0.07
  20. Mariana Jinga · 1 shared paper, 2019 · strength 0.07
  21. ChristophF Dietrich · 1 shared paper, 2019 · strength 0.07
  22. Alina Liliana Constantin · 1 shared paper, 2019 · strength 0.07
  23. Irina Mihaela Cazacu · 1 shared paper, 2019 · strength 0.07
  24. Peter Vilmann · 1 shared paper, 2019 · strength 0.07
  25. Emmanuel S. Coronel · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.